Advanced

 
  Search
    Simple search


Results

4 results
1 - 4 / 4
First pagePrevious page1Next pageLast page
1. Anti-vimentin, anti-TUFM, anti-NAP1L1 and anti-DPYSL2 nanobodies display cytotoxic effect and reduce glioblastoma cell migration
Alja Zottel, Ivana Jovchevska, Neja Šamec, Jernej Mlakar, Jernej Šribar, Igor Križaj, Marija Skoblar Vidmar, Radovan Komel, 2020, original scientific article

Keywords: glioblastoma, glioblastoma stem cells, nanobodies, cell migration, cytotoxicity, vimentin, DPYSL2, NAP1L1, TUFM
Full text (file, 4,45 MB) This document has more files! More...

2. Nanotechnology meets oncology
Alja Zottel, Alja Videtič Paska, Ivana Jovchevska, 2019, review article

Keywords: nanomaterials, brain cancer, nanomedicine, nanoparticles, nanobodies, blood–brain barrier, glioblastoma, nanodiagnostics, nanotherapy
Full text (file, 1,12 MB) This document has more files! More...

3. CDR1 composition can affect nanobody recombinant expression yields
Marco Orlando, Sara Fortuna, Sandra Oloketuyi, Gregor Bajc, Adi Goldenzweig, Ario De Marco, 2021, original scientific article

Keywords: nanobodies, in silico engineering, mutagenesis, nanobody CDRs, in silico modeling, rational mutagenesis, nanobody engineering
Full text (file, 2,37 MB) This document has more files! More...

4. Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma
Eduardo Ruiz-López, Ivana Jovchevska, Alberto J. Schuhmacher, 2022, original scientific article

Keywords: glioblastoma, nanobodies, immunotargeted applications
Full text (file, 3,75 MB) This document has more files! More...
Search done in 0.03 sec.
Back to top